Decreases seen in mortality for acute MI, ischemic heart disease, while increases seen for mortality from other heart disease ...

U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to ...

Research shows heart attack deaths have plummeted by nearly 90% since 1970, while deaths from heart failure and arrhythmias ...

The data, published in the Journal of the American Heart Association, analyzed over 37 million heart disease deaths spanning ...

While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

In 1970, ischemic heart disease—mostly heart attacks—accounted for 91% of heart-related deaths. Today, that number has fallen ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients ...

New data highlight a substantial decline in overall heart disease death rates during the past 50 years, along with a shift in ...

Heart disease is the leading cause of death around the world. However, overall heart disease death rates over the past five ...

The research team found that deaths from other types of heart disease surged 81% over the same 50-year period, with three ...

Thanks to medical advancements, heart attack deaths have dropped nearly 90% in the last 50 years. But deaths from these ...